Xuzhishi Technology

Established in 2015 and based in Hangzhou, China, Hangzhou Xuzhishi Technology Co. , Ltd. , trading as Xuzhishi Technology, operates as an AI brain science medical technology developer that mainly provides brain disease treatment products. It has obtained EU CE and UK MHRA certification.

In 2021, the company launched its first medical device product that uses virtual reality technology for cognitive function rehabilitation. In December 2025, Xuzhishi Technology raised CNY 50 million in series A+ funding from new investors Zheshang Capital Management, XT Venture and Plum Ventures. The company mainly provides brain disease treatment products. It provides products using brain imaging technology, VR, AR, artificial intelligence, and other technologies.

Products include YKVR-1 cognitive function rehabilitation system, VR stroke limb rehabilitation system, digital department solutions, and follow-up management system. The cognitive function rehabilitation system can provide rehabilitation training and data monitoring for patients with depression, Alzheimer's disease, etc. Follow-up management system includes health record management, follow-up program, and health record education. Products and services can be used in hospitals, medical institutions, nursing homes, and other places.

The company generates revenue by providing brain disease treatment products such as cognitive function rehabilitation system and follow-up management system. The company will use the latest funding for the construction of an AI algorithm system for brain diseases, multimodal neural data modeling, accumulation of physical AI training data, and the research and development of XR brain-computer interface hardware.